BIOAF — biOasis Technologies Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $1.49m
- CA$0.04m
Annual cashflow statement for biOasis Technologies, fiscal year end - February 28th, CAD millions except per share, conversion factor applied.
2018 February 28th | 2019 February 28th | 2020 February 29th | 2021 February 28th | 2022 February 28th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.31 | -3.47 | -4.06 | 0.698 | -2.96 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 1.47 | -0.397 | -0.005 | 1.26 | -0.329 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.102 | 0.568 | 0.692 | -0.248 | -0.402 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -3.67 | -3.23 | -3.3 | 1.77 | -3.64 |
| Capital Expenditures | -0.108 | -0.002 | — | — | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | 0.395 | 0 | 0.007 | 0 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.108 | 0.393 | 0 | 0.007 | 0 |
| Financing Cash Flow Items | — | — | — | — | -0.09 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.9 | 3.53 | 2.49 | 0.312 | 2.64 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.124 | 0.682 | -0.784 | 2.16 | -1.01 |